NewsStocks Alnylam Stock Soars on Strong Results in Heart Drug Study by admin 24/06/2024 24/06/2024 Key Takeaways Alnylam Pharmaceuticals announced a Phase-3 study of its treatment for a rare heart … 0 FacebookTwitterPinterestEmail
